作者：
Ashish,Goyal [1]
;
Jens,Bauer [2]
;
Joschka,Hey [3]
;
Dimitris N,Papageorgiou [4]
;
Ekaterina,Stepanova [1]
;
Michael,Daskalakis [5]
;
Jonas,Scheid [6]
;
Marissa,Dubbelaar [7]
;
Boris,Klimovich [8]
;
Dominic,Schwarz [9]
;
Melanie,Märklin [1]
;
Malte,Roerden [10]
;
Yu-Yu,Lin [2]
;
Tobias,Ma [3]
;
Oliver,Mücke [4]
;
Hans-Georg,Rammensee [11]
;
Michael,Lübbert [2]
;
Fabricio,Loayza-Puch [3]
;
Jeroen,Krijgsveld [4]
;
Juliane S,Walz [11]
;
Christoph,Plass [4]
作者单位：
Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[1]
Department of Peptide-based Immunotherapy, University of Tübingen and University Hospital Tübingen, Tübingen, Germany.
[2]
Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
[3]
Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.
[4]
German-Israeli Helmholtz Research School in Cancer Biology, Heidelberg, Germany.
[5]
German Center for Lung Research, (DZL) partner site Heidelberg, Heidelberg, Germany.
[6]
Division of Proteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[7]
Heidelberg University, Medical Faculty, Heidelberg, Germany.
[8]
Translational Control and Metabolism, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[9]
Department of Hematology and Central Hematology Laboratory, Inselspital, Bern, University Hospital, University of Bern, Bern, Switzerland.
[10]
Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.
[11]
Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
[12]
Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
[13]
German Cancer Consortium (DKTK), Heidelberg, Germany.
[14]
Department of Peptide-based Immunotherapy, University of Tübingen and University Hospital Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.
[15]
Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.
[16]
Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.
[17]
Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.
[18]
Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany. c.plass@dkfz.de.
[19]
German Center for Lung Research, (DZL) partner site Heidelberg, Heidelberg, Germany. c.plass@dkfz.de.
[20]
German Cancer Consortium (DKTK), Heidelberg, Germany. c.plass@dkfz.de.
[21]
DOI
10.1038/s41467-023-42417-w
PMID
37872136
发布时间
2023-11-19
换一批
换一批
